In response to the Berlin declaration released by the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) on 19 July, setting out the “Biopharmaceutical industry vision for equitable access in pandemics”, civil society and community representatives to ACT-A have responded with the following statement